VIVOVEC
Live / Applied — Fifth extension granted (statement of use) (as of 30 Oct 2025)
What this means for you
Not registered yet, but its 24 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97474428
- Mark type
- Stylized text
- Filed
- 24 Jun 2022
- Published for opposition
- 11 Apr 2023
- Attorney of record
- Mark A. Jansen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer, all of the foregoing being gene therapy products
- Class 040 — Treatment of materials: Manufacturing services for others in the field of pharmaceutical preparations
- Class 042 — Scientific and technological services: Medical research and scientific research in the fields of immunotherapy and oncology; Medical research consulting and scientific research consulting services in the fields of immunotherapy and oncology
- Class 044 — Medical, beauty and agricultural services: Medical consulting services in the fields of immunotherapy and oncology
Owner
- Umoja Biopharma, Inc., Seattle, WA, US
- Umoja Biopharma, Inc., Seattle, WA, US
Prosecution history
- 31 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Oct 2025 — SOU EXTENSION 5 GRANTED
- 28 Oct 2025 — SOU EXTENSION 5 FILED
- 29 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Mar 2025 — SOU EXTENSION 4 GRANTED
- 20 Mar 2025 — SOU EXTENSION 4 FILED
- 20 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Nov 2024 — SOU EXTENSION 3 GRANTED
- 11 Nov 2024 — SOU EXTENSION 3 FILED
- 11 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 08 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2024 — SOU EXTENSION 2 GRANTED
- 07 May 2024 — SOU EXTENSION 2 FILED